Cargando…
Polyisoprenylated Methylated Protein Methyl Esterase Is Both Sensitive to Curcumin and Overexpressed in Colorectal Cancer: Implications for Chemoprevention and Treatment
Inhibition of PMPMEase, a key enzyme in the polyisoprenylation pathway, induces cancer cell death. In this study, purified PMPMEase was inhibited by the chemopreventive agent, curcumin, with a K (i) of 0.3 μM (IC(50) = 12.4 μM). Preincubation of PMPMEase with 1 mM curcumin followed by gel-filtration...
Autores principales: | Amissah, Felix, Duverna, Randolph, Aguilar, Byron J., Poku, Rosemary A., Lamango, Nazarius S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3713324/ https://www.ncbi.nlm.nih.gov/pubmed/23936796 http://dx.doi.org/10.1155/2013/416534 |
Ejemplares similares
-
Polyisoprenylated methylated protein methyl esterase as a putative drug target for androgen-insensitive prostate cancer
por: Poku, Rosemary A, et al.
Publicado: (2014) -
The antiangiogenic effects of polyisoprenylated cysteinyl amide inhibitors in HUVEC, chick embryo and zebrafish is dependent on the polyisoprenyl moiety
por: Nkembo, Augustine T., et al.
Publicado: (2016) -
Polyisoprenylated cysteinyl amide inhibitors disrupt actin cytoskeleton organization, induce cell rounding and block migration of non-small cell lung cancer
por: Ntantie, Elizabeth, et al.
Publicado: (2017) -
Polyisoprenylated cysteinyl amide inhibitors deplete singly polyisoprenylated monomeric G-proteins in lung and breast cancer cell lines
por: Tawfeeq, Nada, et al.
Publicado: (2023) -
Synthetic Optimization and MAPK Pathway Activation Anticancer Mechanism of Polyisoprenylated Cysteinyl Amide Inhibitors
por: Tawfeeq, Nada, et al.
Publicado: (2021)